<?xml version="1.0" encoding="UTF-8"?>
<p>Moreover, another research paper illustrates six clinical trials of Phase I listed in the list of Clinicaltrials.gov [
 <xref rid="B54" ref-type="bibr">54</xref>]. The health and immunogenicity of their respective MERS-CoV vaccine applicants are both checked but have yet to be released [
 <xref rid="B55" ref-type="bibr">55</xref>]. The trials will be finished by December 2020 (two Russian studies) [
 <xref rid="B54" ref-type="bibr">54</xref>] and December 2021 (German study) [
 <xref rid="B54" ref-type="bibr">54</xref>]. Medicago company has announced the development of a plant-based vaccine for the SARS-CoV-2 release in March 2020. Besides, further attempts for vaccine development from Moderna utilizing mRNA platform, Inovios DNA vaccine and College of Medicine and University of Queensland's utilizing subunit recombinant expression of potential vaccines [
 <xref rid="B56" ref-type="bibr">56â€“63</xref>].
</p>
